Biomarker Candidate Platforms for Inflammatory Diseases (U44)
The summary for the Biomarker Candidate Platforms for Inflammatory Diseases (U44) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Biomarker Candidate Platforms for Inflammatory Diseases (U44): This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) Fast Track grant applications that propose to test and/or validate novel, state-of-the-art candidate biomarker platforms for predicting the onset and progression of inflammatory diseases of interest to the NIAMS and for determining the pharmacodynamics, safety and/or efficacy of therapeutic agents targeting those diseases.
Federal Grant Title: | Biomarker Candidate Platforms for Inflammatory Diseases (U44) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-AR-14-004 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.846 |
CFDA Descriptions: | Arthritis, Musculoskeletal and Skin Diseases Research |
Current Application Deadline: | Oct 11, 2013 |
Original Application Deadline: | Oct 11, 2013 |
Posted Date: | Apr 29, 2013 |
Creation Date: | Apr 29, 2013 |
Archive Date: | Nov 11, 2013 |
Total Program Funding: | $450,000 |
Maximum Federal Grant Award: | $225,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 2 |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 ...
- • Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 ...
- • Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Cli...
- • Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed)
- • NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)
- • Collaborative Arthritis and Musculoskeletal and Skin Diseases Science Award (Camssa)
- • Niams Small Grant Program for New Investigators
- • Skin Diseases Research Core Centers
- More Grants from the National Institutes of Health
- • The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Preven...
- • Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
- • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...